Well think about it for a sec. Cytodyn made a deal for the US HIV market with Vyera, Vyrologix does make sense as the name of Leronlimab for that specific company. I have a feeling that many more names will come into play once we make more and more deals. There were 4 or 5 names listed on the sec filing.. Maybe hints as to who..

This way the price per indication can be different, but not sure why a doctor would not just write an off label prescription if one is cheaper, maybe insurance? Can't really comment on that, maybe someone with more knowledge would know. Just my guesses...